After-Hours Stock Movers 02/04: (USNA) (MKSI) (PYPL) Higher; (PLT) (KN) (ZIOP) Lower (more...)

Stifel Reiterates Buy Rating on Nike (NKE) Following Showcase

Stifel analyst Jim Duffy reiterated a Buy rating and $110.00 price target on Nike (NYSE: NKE) following an event in New York. NIKE showcased product innovations to be launched around the Tokyo Olympics this summer.

The show featured a diverse range of Olympic/Paralympic... More

Ziopharm Oncology (ZIOP) Prices 27.83M Share Common Offering at $3.25/Sh

Ziopharm Oncology, Inc. (NASDAQ: ZIOP) today announced the pricing of an underwritten public offering of 27,826,086 shares of its common stock at a public offering price of $3.25 per share. Ziopharm has granted the underwriters a 30-day option to purchase up to an additional 4,173,912... More

Knowles Corp (KN) PT Lowered to $21 at Susquehanna

Susquehanna analyst Christopher Rolland lowered the price target on Knowles Corp (NYSE: KN) to $21.00 (from $25.00) while maintaining a Positive rating.

The analyst commented, "While we thought the company had matured beyond a pattern of common resets, we were wrong, as management cut expectations once again and added execution risk for 2020."

SunTrust Reiterates Buy Rating on New Relic (NEWR) Following 3Q Report

SunTrust analyst Joel Fishbein Jr. reiterated a Buy rating and $85.00 price target on New Relic (NYSE: NEWR) following the company's 3Q earnings report. The Company reported $153M of revenue for 3Q20, ahead of consensus at $149M and the high end of guidance at... More

BMO Capital Downgrades New Relic (NEWR) to Market Perform

BMO Capital analyst Keith Bachman downgraded New Relic (NYSE: NEWR) from Outperform to Market Perform with a price target of $72.00 (from $78.00).

The analyst comments "While we acknowledge that NEWR has an inexpensive valuation at less than 5x revs, we are skeptical about... More